Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45α expression to increase cell survival

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Chiou, Hsin Ying Clair ^a   Liu, Shau Yu ^b   Lin, Cheng Hsiung ^b   Lee, Eminy Hy ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cell survival; GADD45 ; Hes 1; PIAS1; SUMOylation

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; PIAS1 PROTEIN; PROTEIN ANTIBODY; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT 1; PROTEIN INHIBITOR OF ACTIVATED STAT 2; PROTEIN INHIBITOR OF ACTIVATED STAT 3; STAT1 PROTEIN; SUMO 1 ANTIBODY; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR HES 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HYDROGEN PEROXIDE; NUCLEAR PROTEIN; STAT1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME SPECIFICITY; GENOMIC INSTABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION INITIATION SITE; UBIQUITINATION; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION;

APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; HYDROGEN PEROXIDE; NUCLEAR PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SUMOYLATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84903729274     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-53     Document Type: Article

References (66)

1. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R, EMBO J 1999 18 2196 2207 10.1093/emboj/18.8.2196 10205173 (Pubitemid 29179176)
2. Enhancer of splitD, a dominant mutation of Drosophila, and its use in the study of functional domains of a helix-loop-helix protein. Tietze K, Oellers N, Knust E, Proc Natl Acad Sci U S A 1992 89 6152 6156 10.1073/pnas.89.13.6152 1631102
3. JNK1 inhibits GluR1 expression and GluR1-mediated calcium influx through phosphorylation and stabilization of Hes-1. Lin CH, Lee EH, J Neurosci 2012 32 1826 1846 10.1523/JNEUROSCI.3380-11.2012 22302822
4. Mediation of NGF signaling by post-translational inhibition of HES-1, a basic helix-loop-helix repressor of neuronal differentiation. Strom A, Castella P, Rockwood J, Wagner J, Caudy M, Genes Dev 1997 11 3168 3181 10.1101/gad.11.23.3168 9389649 (Pubitemid 27528057)
5. Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Ju BG, Solum D, Song EJ, Lee KJ, Rose DW, Glass CK, Rosenfeld MG, Cell 2004 119 815 829 10.1016/j.cell.2004.11.017 15607978 (Pubitemid 40017688)
6. Protein modification by SUMO. Johnson ES, Annu Rev Biochem 2004 73 355 382 10.1146/annurev.biochem.73.011303.074118 15189146 (Pubitemid 39050373)
7. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Gareau JR, Lima CD, Nat Rev Mol Cell Biol 2010 11 861 871 10.1038/nrm3011 21102611
8. Regulation of cytokine signaling pathways by PIAS proteins. Shuai K, Cell Res 2006 16 196 202 10.1038/sj.cr.7310027 16474434 (Pubitemid 43247977)
9. Targeting the PIAS1 SUMO ligase pathway to control inflammation. Liu B, Shuai K, Trends Pharmacol Sci 2008 29 505 509 10.1016/j.tips.2008.07.008 18755518
10. PIAS/SUMO: new partners in transcriptional regulation. Schmidt D, Muller S, Cell Mol Life Sci 2003 60 2561 2574 10.1007/s00018-003-3129-1 14685683 (Pubitemid 38041360)
11. Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning. Tai DJ, Hsu WL, Liu YC, Ma YL, Lee EH, EMBO J 2011 30 205 220 10.1038/emboj.2010.290 21102409
12. SUMO modification regulates the transcriptional activity of MAML1. Lindberg MJ, Popko-Scibor AE, Hansson ML, Wallberg AE, FASEB J 2010 24 2396 2404 10.1096/fj.09-149401 20203086
13. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K, Talanta 1997 44 1299 1305 10.1016/S0039-9140(97)00017-9 18966866 (Pubitemid 27249311)
14. A new protease required for cell-cycle progression in yeast. Li SJ, Hochstrasser M, Nature 1999 398 246 251 10.1038/18457 10094048 (Pubitemid 29142860)
15. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Hochstrasser M, Cell 2001 107 5 8 10.1016/S0092-8674(01)00519-0 11595179 (Pubitemid 32972031)
16. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F, Cell 2002 108 109 120 10.1016/S0092-8674(01) 00633-X 11792325 (Pubitemid 34137016)
17. The polycomb protein Pc2 is a SUMO E3. Kagey MH, Melhuish TA, Wotton D, Cell 2003 113 127 137 10.1016/S0092-8674(03)00159-4 12679040 (Pubitemid 36411965)
18. PIAS proteins: pleiotropic interactors associated with SUMO. Rytinki MM, Kaikkonen S, Pehkonen P, Jaaskelainen T, Palvimo JJ, Cell Mol Life Sci 2009 66 3029 3041 10.1007/s00018-009-0061-z 19526197
19. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. Miyauchi Y, Yogosawa S, Honda R, Nishida T, Yasuda H, J Biol Chem 2002 277 50131 50136 10.1074/jbc.M208319200 12393906 (Pubitemid 36014466)
20. HES1 is a novel interactor of the Fanconi anemia core complex. Tremblay CS, Huang FF, Habi O, Huard CC, Godin C, Levesque G, Carreau M, Blood 2008 112 2062 2070 10.1182/blood-2008-04-152710 18550849
21. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Kotaja N, Karvonen U, Janne OA, Palvimo JJ, Mol Cell Biol 2002 22 5222 5234 10.1128/MCB.22.14.5222-5234.2002 12077349 (Pubitemid 34700711)
22. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Bossis G, Melchior F, Mol Cell 2006 21 349 357 10.1016/j.molcel.2005. 12.019 16455490 (Pubitemid 43163530)
23. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C, Mol Cell Proteomics 2011 10 111 013284 10.1074/mcp.M111.013284 21890473
24. PDSM, a motif for phosphorylation-dependent SUMO modification. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A, Sistonen L, Proc Natl Acad Sci U S A 2006 103 45 50 10.1073/pnas.0503698102 16371476 (Pubitemid 43076102)
25. SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses. Yao Q, Li H, Liu BQ, Huang XY, Guo L, J Biol Chem 2011 286 27342 27349 10.1074/jbc.M111.220848 21685386
26. Modification with SUMO. A role in transcriptional regulation. Verger A, Perdomo J, Crossley M, EMBO Rep 2003 4 137 142 10.1038/sj.embor.embor738 12612601 (Pubitemid 36322153)
27. Increased expression of the homologue of enhancer-of-split 1 protects neurons from beta amyloid neurotoxicity and hints at an alternative role for transforming growth factor beta1 as a neuroprotector. Chacon PJ, Rodriguez-Tebar A, Alzheimers Res Ther 2012 4 31 10.1186/alzrt134 22849569
28. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Fischer A, Gessler M, Nucleic Acids Res 2007 35 4583 4596 10.1093/nar/gkm477 17586813 (Pubitemid 47250333)
29. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death. Leitao BB, Jones MC, Brosens JJ, FASEB J 2011 25 3416 3425 10.1096/fj.11-186346 21676946
30. Gadd45 proteins: relevance to aging, longevity and age-related pathologies. Moskalev AA, Smit-McBride Z, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Tacutu R, Fraifeld VE, Ageing Res Rev 2012 11 51 66 10.1016/j.arr.2011.09.003 21986581
31. DNA damage-inducible transcripts in mammalian cells. Fornace AJ Jr, Alamo I Jr, Hollander MC, Proc Natl Acad Sci U S A 1988 85 8800 8804 10.1073/pnas.85.23.8800 3194391 (Pubitemid 19001796)
32. Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. Zhang W, Hoffman B, Liebermann DA, Int J Oncol 2001 18 749 757 11251170
33. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Jackman J, Alamo I Jr, Fornace AJ Jr, Cancer Res 1994 54 5656 5662 7923213 (Pubitemid 24346263)
34. 2 involves DNA-damage-and-repair genes and telomere shortening. Duan J, Duan J, Zhang Z, Tong T, Int J Biochem Cell Biol 2005 37 1407 1420 10.1016/j.biocel.2005.01.010 15833273
35. Nucleolin links to arsenic-induced stabilization of GADD45alpha mRNA. Zhang Y, Bhatia D, Xia H, Castranova V, Shi X, Chen F, Nucleic Acids Res 2006 34 485 495 10.1093/nar/gkj459 16421274 (Pubitemid 43245430)
36. Role of Gadd45 in apoptosis. Sheikh MS, Hollander MC, Fornance AJ Jr, Biochem Pharmacol 2000 59 43 45 10.1016/S0006-2952(99)00291-9 10605933
37. Hairy function as a DNA-binding helix-loop-helix repressor of Drosophila sensory organ formation. Ohsako S, Hyer J, Panganiban G, Oliver I, Caudy M, Genes Dev 1994 8 2743 2755 10.1101/gad.8.22.2743 7958930 (Pubitemid 24375423)
38. Gadd45α protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace AJ Jr, Cancer Res 2002 62 7305 7315 12499274 (Pubitemid 36025254)
39. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Takekawa M, Saito H, Cell 1998 95 521 530 10.1016/S0092-8674(00)81619-0 9827804 (Pubitemid 28533308)
40. Hematopoietic cells from Gadd45α- and Gadd45β-deficient mice are sensitized to genotoxic-stress-induced apoptosis. Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebermann DA, Oncogene 2005 24 7170 7179 10.1038/sj.onc.1208847 16170381 (Pubitemid 41679279)
41. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Martin S, Wilkinson KA, Nishimune A, Henley JM, Nat Rev Neurosci 2007 8 948 959 10.1038/nrn2276 17987030 (Pubitemid 350146936)
42. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor. Honjo T, Genes Cells 1996 1 1 9 10.1046/j.1365-2443.1996. 10010.x 9078362 (Pubitemid 126673102)
43. Notch signaling: cell fate control and signal integration in development. Artavanis-Tsakonas S, Rand MD, Lake RJ, Science 1999 284 770 776 10.1126/science.284.5415.770 10221902 (Pubitemid 29291335)
44. Hes1 and Hes5 activities are required for the normal development of the hair cells in the mammalian inner ear. Zine A, Aubert A, Qiu J, Therianos S, Guillemot F, Kageyama R, de Ribaupierre F, J Neurosci 2001 21 4712 4720 11425898 (Pubitemid 32565629)
45. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Kita A, Imayoshi I, Hojo M, Kitagawa M, Kokubu H, Ohsawa R, Ohtsuka T, Kageyama R, Hashimoto N, Mol Endocrinol 2007 21 1458 1466 10.1210/me.2007-0039 17426285 (Pubitemid 46984750)
46. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD, J Biol Chem 2001 276 18513 18518 10.1074/jbc.M008066200 11278381
47. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. Wei F, Scholer HR, Atchison ML, J Biol Chem 2007 282 21551 21560 10.1074/jbc.M611041200 17525163 (Pubitemid 47099909)
48. SUMO-1 possesses DNA binding activity. Eilebrecht S, Smet-Nocca C, Wieruszeski JM, Benecke A, BMC Res Notes 2010 3 146 10.1186/1756-0500-3-146 20504299
49. Analysis of the mammalian gadd45 gene and its response to DNA damage. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr, J Biol Chem 1993 268 24385 24393 8226988 (Pubitemid 23335431)
50. BRCA1 activation of the GADD45 promoter. Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ Jr, Zhan Q, Oncogene 2000 19 4050 4057 10.1038/sj.onc.1203759 10962562
51. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N, Furuichi K, Sakai T, Oncogene 2003 22 7762 7773 10.1038/sj.onc.1207091 14586402 (Pubitemid 37485535)
52. The involvement of WT1 in the regulation of GADD45α in response to genotoxic stress. Johnson D, Hastwell PW, Walmsley RM, Mutagenesis 2013 28 393 399 10.1093/mutage/get015 23476008
53. Myc represses the growth arrest gene gadd45. Marhin WW, Chen S, Facchini LM, Fornace AJ Jr, Penn LZ, Oncogene 1997 14 2825 2834 10.1038/sj.onc.1201138 9190899 (Pubitemid 27313415)
54. Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents. Amundson SA, Zhan Q, Penn LZ, Fornace AJ Jr, Oncogene 1998 17 2149 2154 10.1038/sj.onc.1202136 9811446 (Pubitemid 28515368)
55. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. Moriyama M, Osawa M, Mak SS, Ohtsuka T, Yamamoto N, Han H, Delmas V, Kageyama R, Beermann F, Larue L, Nishikawa S, J Cell Biol 2006 173 333 339 10.1083/jcb.200509084 16651378
56. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J, Zweidler-McKay PA, Blood 2011 117 2891 2900 10.1182/blood-2009-12-253419 21224467
57. Notch activation inhibits AML growth and survival: a potential therapeutic approach. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-Mckay PA, J Exp Med 2013 210 321 337 10.1084/jem.20121527 23359069
58. Hydrogen peroxide activates IκB kinases through phosphorylation of serine residues in the activation loops. Kamata H, Manabe T, Oka SI, Kamata K, Hirata H, FEBS Lett 2002 519 231 237 10.1016/S0014-5793(02)02712-6 12023051 (Pubitemid 34522025)
59. Proinflammatory stimuli induce IKKα-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Liu B, Yang Y, Chernishof V, Ogorzalek Loo RR, Jang H, Tahk S, Yang R, Mink S, Shultz D, Bellone CJ, Loo JA, Shuai K, Cell 2007 129 903 914 10.1016/j.cell.2007.03.056 17540171 (Pubitemid 46802704)
60. 2 cytotoxicity in mouse renal proximal tubule cells. Arany I, Megyesi JK, Kaneto H, Tanaka S, Safirstein RL, Kidney Int 2004 65 1231 1239 10.1111/j.1523-1755.2004.00500.x 15086462 (Pubitemid 38406961)
61. Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation. Liu B, Shuai K, J Biol Chem 2001 276 36624 36631 10.1074/jbc.M101085200 11451946
62. STAT-1: a novel regulator of apoptosis. Stephanou A, Latchman DS, Int J Exp Pathol 2003 84 239 244 14748743 (Pubitemid 38221802)
63. STAT1 as a key modulator of cell death. Kim HS, Lee MS, Cell Signal 2007 19 454 465 10.1016/j.cellsig.2006.09.003 17085014 (Pubitemid 46107818)
64. STAT1 negatively regulates spatial memory formation and mediates the memory-impairing effect of Abeta. Hsu WL, Ma YL, Hsieh DY, Liu YC, Lee EH, Neuropsychopharmacology 2014 39 746 758 10.1038/npp.2013.263 24081304
65. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO, Oncogene 2006 25 7555 7564 10.1038/sj.onc.1209742 16799645 (Pubitemid 44924469)
66. A novel defense mechanism that is activated on amyloid-beta insult to mediate cell survival: role of SGK1-STAT1/STAT2 signaling. Hsu WL, Chiu TH, Tai DJ, Ma YL, Lee EH, Cell Death Differ 2009 16 1515 1529 10.1038/cdd.2009.91 19609277